COMMUNIQUÉS West-GlobeNewswire

SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
10/07/2026
Taipei, TAIWAN, July 10, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and [...]
Frishantic Launches Vitamin D3 K2 5000 IU Supplement for Indoor-Heavy Lifestyles
10/07/2026
A one-daily softgel formula designed to support bone health, normal immune function, and daily wellness for adults navigating modern indoor routines. NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- Frishantic , a wellness [...]
BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
10/07/2026
NETANYA, Israel, July 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a company focused on defense, security, and critical infrastructure technologies, today announced that its [...]
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials
10/07/2026
Interview Highlights Thompson's Entrepreneurial Vision and Kraig Labs' Mission to Bring Spider Silk to Commercial Scale ANN ARBOR, Mich., July 10, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB [...]
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
10/07/2026
Advances progress towards planned Nasdaq uplisting POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
10/07/2026
Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq [...]
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
10/07/2026
Company to host scientific workshop featuring emerging eMTBR-Tau and BD-pTau217 research data for Alzheimer’s disease detection and staging FREMONT, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. ( [...]
UREVO Wins Red Dot Award 2026 for AI-Powered Wireless Recovery Boots
10/07/2026
ESSEN, Germany, July 10, 2026 (GLOBE NEWSWIRE) -- Smart wellness innovator UREVO has won the Red Dot Award: Product Design 2026 in the Innovative Design category for its AI-Powered Wireless Recovery Boots . The honor [...]
No easy answers: European research consortia take on major challenges
10/07/2026
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health [...]
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
10/07/2026
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China ADELAIDE, Australia, July 10, 2026 (GLOBE NEWSWIRE) -- Avance [...]
MindRank Announces $52 Million Series B Financing
10/07/2026
Funding to advance MindRank’s AI-native drug R&D engine and innovative pipeline, including MDR-001, an oral small-molecule GLP-1 receptor agonist in Phase III clinical development in China HANGZHOU, China, July 09, [...]
Cue Biopharma Announces $50.0 Million Private Placement
10/07/2026
BOSTON, July 09, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical stage biopharmaceutical company focused on developing transformative therapies targeting functional cures for immunological [...]
Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026
10/07/2026
Continued Growth Underpins First Full Year Net Revenue of US$115M NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory [...]
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
10/07/2026
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China ADELAIDE, Australia, July 10, 2026 (GLOBE NEWSWIRE) -- Avance [...]
Foundation for Sarcoidosis Research Announces New Partnership with Patient Advocate Foundation to Expand Insurance and Disability Support for Sarcoidosis Patients
09/07/2026
CHICAGO, July 09, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for those living with the [...]
Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
09/07/2026
This recommendation represents an important step towards improving access for Canadians living with rare kidney diseases WALTHAM, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: [...]
L’Agence des médicaments du Canada émet une recommandation favorable au remboursement d’EMPAVELI (pegcétacoplan) dans le traitement de la C3G et de la IC-MPGN primaire
09/07/2026
Cette recommandation constitue une avancée majeure vers l’amélioration de l’accès aux soins pour les Canadiens atteints de néphropathies rares WALTHAM, Mass., 09 juill. 2026 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum [...]
Oh!mino Survey Finds GLP-1 Muscle Loss Concerns Drive New Focus on Preserving Muscle While Dieting
09/07/2026
Seal Beach, CA, July 09, 2026 (GLOBE NEWSWIRE) -- Oh!Nutrition, a California-based nutritional product development company, has released company survey findings from more than 500 Oh!mino users taking GLP-1 medications [...]
Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants
09/07/2026
Daix (France), New York City (New York, United States), July 9, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the development [...]

Pages